Diagnostic strategy in heparin induced thrombocytopenia

Eastern Journal of Medicine

Volumn 14, Issue 2, 2009, Pages 78-83

  Kannan, Meganathan ^a,d   Ahmad, Sarfraz ^b   Fareed, Jawed ^c   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Clinical and laboratory diagnosis; Diagnostic approach; Trombocytopenia

Indexed keywords

CARBON 14; FC RECEPTOR IIA; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; THROMBIN ANTITHROMBIN COMPLEX;

BLEEDING; CELL ACTIVATION; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUID PHASE DETECTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HEART INFARCTION; HEPARIN INDUCED PLATELET AGGREGATION ASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; LEG THROMBOSIS; LUNG EMBOLISM; PARTICLE GEL IMMUNOASSAY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT MONITORING; REVIEW; SENSITIVITY AND SPECIFICITY; SEROTONIN RELEASE ASSAY; SKIN DEFECT; SOLID PHASE DETECTION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; THROMBOSIS; WILD TYPE;

EID: 77955869101     PISSN: 13010883     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Warkentin TE. Heparin-induced thrombocytopenia. Hematol Oncol Clin North Am 2007; 21: 1-607.
2. Gitau MM, Arora N. Heparin-induced thrombocytopenia. Mo Med 2009; 106: 1-54.
3. Kelton JG, Warkentin TE. Heparin-induced thrombocytopenia: a historical perspective. Blood 2008; 112: 1-2616.
4. Unkle DW. Heparin-induced thrombocytopenia. Orthop Nurs 2007; 26: 1-5. quiz 1-387.
5. Amiral J, Marfaing-Koka A, Poncz M, Meyer D. The biological basis of heparin-induced thrombocytopenia. Platelets 1998; 9: 1-91.
6. Swanson JM. Heparin-induced thrombocytopenia: a general review. J Infus Nurs 2007; 30: 1-240.
7. Girolami B, Girolami A. Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost 2006; 32: 1-809.
8. Warkentin TE. Clinical picture of HIT. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenis. 3rd Edition. New York, NY: Marcel Dekker 2004; 1-106.
9. Kannan M, Saxena R, Adiguzel C, Fareed J. An update on the prevalence and characterization of HPF4 antibodies in Asian-Indian patients. Semin Thromb Hemost 2009; 35: 1-343.
10. Ahmad S, Untch B, Haas S, et al. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: Implications in the HIT pathogenesis. Mol Cell Biochem 2004; 258: 1-170.
11. Fabris F, Ahmad S, Cella G, Jeske WP, Walenga JM, Fareed J. Pathophysiology of heparin-induced thrombocytopenia: Clinical and diagnostic implications - a review. Arch Pathol Lab Med 2000; 124: 1-1666.
12. Castelli R, Cassinerio E, Cappellini MD, Porro F, Graziadei G, Fabris F. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects. Cardiovasc Hematol Disord Drug Targets 2007; 7: 1-162.
13. Kannan M, Ahmed R, Kale S, Ahmad S, Fareed J, Saxena R. Laboratory diagnosis of heparin-induced thrombocytopenia in Asian Indians as investigated with functional and immunologic methods. Clin Appl Thromb Hemost 2004; 10: 1-54.
14. Elalamy I, Lecrubier C, Horellou MH, Conard J, Samama MM. Heparin-induced thrombocytopenia: Laboratory diagnosis and management. Ann Med 2000; 32: 1-67.
15. Prechel M, Walenga JM. The laboratory diagnosis and clinical management of patients with heparininduced thrombocytopenia: an update. Semin Thromb Hemost 2008; 34: 1-96.
16. Kannan M, Ahmad S, Ahmad F, et al. Functional characterization of antibodies against heparin-PF4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: Relevance to inflammatory markers Blood Coagul Fibrinolysis 2005; 16: 1-490.
17. Walenga JM, Jeske WP, Wood JJ, Ahmad S, Lewis BE, Bakhos M. Laboratory tests for heparininduced thrombocytopenia: A multicenter study. Semin Hematol 1999; 36: 1-28.
18. Lee DH, Warkentin TE, Denomme GA, Hayward CP, Kelton JG. A diagnostic test for heparininduced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol 1996; 95: 1-731.
19. Risch L, Bertschmann W, Heijnen IA, Huber AR. A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients. Blood Coagul Fibrinolysis 2003; 14: 1-106.
20. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: Recognition, treatment, and prevention. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 311S-337S.
21. Brandt JT, Isenhart CE, Osborne JM, et al. Anderson, 1995. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia. Thromb. Haemost 1995; 74: 1-1572.
22. Lehrnbecher TL, Foster CB, Zhu S, et al. Blauvelt and S.J. Chanock, Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men. Blood 2000; 95: 1-2390.
23. Harenberg J, Wehling M. Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Semin Thromb Hemost. 2008; 34: 1-57.
24. Fareed J, Hoppensteadt DA, Fareed D, et al. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin Thromb Hemost 2008; 34: 1-73.
25. Krauel K, Fürll B, Warkentin TE, et al. Heparininduced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes. J Thromb Haemost 2008; 6: 1-2167.
26. Selleng K, Selleng S, Greinacher A. Heparininduced thrombocytopenia in intensive care patients. Semin Thromb Hemost 2008; 34: 425-438.
27. DiGiovanni CW. Current concepts review: heparininduced thrombocytopenia. Foot Ankle Int. 2008; 29: 1-1167.
28. Selleng K, Selleng S, Greinacher A. Heparininduced thrombocytopenia in intensive care patients. Semin Thromb Hemost 2008; 34: 425-438.
29. Hassell K. Heparin-induced thrombocytopenia: diagnosis and management. Thromb Res 2008; 123 11: S1-21.
30. Kelton JG, Warkentin TE. Heparin-induced thrombocytopenia: a historical perspective. Blood. 2008; 112: 1-2616.
31. Alberio L. Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment. Curr Opin Hematol 2008; 15: 1-464.
32. Linkins LA, Warkentin TE. The approach to heparin-induced thrombocytopenia. Semin Respir Crit Care Med 2008; 29: 1-74.
33. Kannan M, Ahmad F, Ahmad S, et al. Heparin-PF4 Antibodies in Heparin Induced Thrombocytopenia: Its Relationship with FcgRIIa Polymorphism. Am J Immunol. 2005; 1: 1-59.
34. Warkentin TE. Clinical picture of HIT. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenis. 3rd Edition. New York, NY: Marcel Dekker 2004; 1-106.
35. Kannan M, Ahmad S, Ahmad F, et al.Functional characterization of antibodies against heparin-PF4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: Relevance to inflammatory markers Blood Coagul Fibrinolysis 2005; 16: 1-490.
36. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 1-30.
37. Walenga JM, Jeske WP, Wood JJ, et al. Laboratory tests for heparin-induced thrombocytopenia: A multicenter study. Semin Hematol 1999; 36: 1-28.
38. Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest 2005; 127: 35S-45S.
39. Zwicker JI, Uhl L, Huang WY, et al. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2004; 2: 1-2137.
40. Chilver-Stainer L, Lammle B, Alberio L. Titre of anti-heparin/PF4 antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems. Thromb Haemost 2004; 91: 1-282.
41. Brieger DB, Mak KH, Kottke-Marchant K. Heparin-induced thrombocytopenia. J. Am. Coll. Cardiol 1998; 31: 1-1459.
42. Carlsson LE, Santoso S, Baurichter G, et al. Greinacher, Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood 1998; 92: 1526-1531.
43. Warkentin TE, Kelton JG. A 14 year study of heparin induced thrombocytopenia. Am. J. Med 1996; 101: 1-507.
44. Nand S, Wong W, Yuen B, et al. Heparin Induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors and clinical outcomes in 108 consecutive patients treated as a single institution. Am J Hematol 1997; 56: 1-16.